LISATA THERAPEUTICS, INC. Impairment of Intangible Assets, Finite-lived
LISATA THERAPEUTICS, INC. (LSTA) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2018-03-22
- LISATA THERAPEUTICS, INC. impairment of intangible assets, finite-lived for fiscal 2016 was $0.00.
- LISATA THERAPEUTICS, INC. impairment of intangible assets, finite-lived for fiscal 2015 was $0.00.
- LISATA THERAPEUTICS, INC. impairment of intangible assets, finite-lived for fiscal 2014 was $0.00.
- LISATA THERAPEUTICS, INC. impairment of intangible assets, finite-lived for fiscal 2013 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-17 | $62.27M 10-K · filed 2016-03-15 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 | |
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |